Conjunctivitis: Clinical Trials

4 trials for Conjunctivitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 recruiting. 4 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Recruiting 4
Phase 11Recruiting 1

Follow Conjunctivitis: new trials by email Literature Review of Conjunctivitis trials Research Report on Conjunctivitis

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of SUM-191 for Patients With Bacterial Conjunctivitis
SUM-191, Placebo - Bacterial Conjunctivitis
Phase 1 / Phase 2RecruitingSenju USA, Inc.4262026-06-252026-06-30
A Study to Compare the Effectiveness and Safety of T1695 Versus Ciclosporin in Participants With Moderate to Severe Vernal Keratoconjunctivitis
Slit Lamp Examination, Far Best Corrected Visual Acuity (BCVA), T1695 - Moderate to Severe Vernal Keratoconjunctivitis
Phase 2RecruitingLaboratoires Thea1202026-03-242026-04-22
Evaluation of TL-925 for the Treatment of Seasonal Allergic Conjunctivitis
TL-925, Placebo - Allergic Conjunctivitis
Phase 2RecruitingTelios Pharma, Inc.602025-10-232025-11-25
Evaluation of TL-925 for the Treatment of Allergic Conjunctivitis
TL-925, Placebo - Allergic Conjunctivitis
Phase 2RecruitingTelios Pharma, Inc.662024-10-032024-11-13

Narrower conditions

Conjunctivitis, Allergic (3)  ·  Conjunctivitis, Bacterial (1)

Broader conditions

Conjunctival Diseases (4)  ·  Eye Diseases (4)  ·  Hypersensitivity (3)  ·  Hypersensitivity, Immediate (3)  ·  Immune System Diseases (3)  ·  Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)  ·  Eye Infections (1)  ·  Eye Infections, Bacterial (1)  ·  Infections (1)

Interventions

Cyclosporine (1)  ·  Slit Lamp Microscopy (1)

Sponsors

Telios Pharma, Inc. (2)  ·  Laboratoires Thea (1)  ·  Senju USA, Inc. (1)

Countries

United States (3)  ·  India (1)

NIH funding

2025 (1)